fda drug shortages semaglutide injection shortage resolved 2025 The weight loss is over — and some patients are 'panicking' Compounded Semaglutide & Tirzepatide 2025:

Some patients taper or discontinue semaglutide after reaching their goal weight, but this should always be done under medical supervision

Safety : Insufficient needle length or incorrect gauge can lead to complications like medication leakage or tissue irritation

If motivation is absent, erection alone does not address the underlying issue

Important safety considerations include: Cardiovascular history : Patients with established cardiovascular disease require careful assessment, though recent evidence suggests GLP-1 receptor agonists may offer cardiovascular benefits Medication interactions : No clinically significant interactions are expected between GLP-1 receptor agonists and statins or other lipid-lowering medications, though delayed gastric emptying could theoretically affect absorption of oral medications Pancreatitis risk : Whilst rare, acute pancreatitis has been reported with GLP-1 receptor agonists